Our study successfully elucidated the phenomenon and mechanism of UA-induced ferroptosis in lung cancer, specifically through the modulation of the FADS2-mediated unsaturated fatty acid synthesis suggesting that UA holds potential as a therapeutic agent for NSCLC, and providing a novel approach for the treatment of NSCLC. Here, FADS2 is linked to lung carcinoma.